The 2021 ESC Guidelines on cardiovascular disease prevention highlight that patients with HIV infection develop more frequently atherosclerotic peripheral artery disease and coronary artery complications [22] compared to the general population and that the risk is two-fold greater in those patients with CD4+ < 200 cells/mm3. This evidence concerns the gene CD4 and cardiovascular disorder.